Sarah Thirkell

555 total citations
8 papers, 283 citations indexed

About

Sarah Thirkell is a scholar working on Oncology, Transplantation and Physiology. According to data from OpenAlex, Sarah Thirkell has authored 8 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Transplantation and 3 papers in Physiology. Recurrent topics in Sarah Thirkell's work include Renal Transplantation Outcomes and Treatments (4 papers), CAR-T cell therapy research (4 papers) and Biomedical Ethics and Regulation (3 papers). Sarah Thirkell is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), CAR-T cell therapy research (4 papers) and Biomedical Ethics and Regulation (3 papers). Sarah Thirkell collaborates with scholars based in United Kingdom. Sarah Thirkell's co-authors include Giovanna Lombardi, Robert I. Lechler, Niloufar Safinia, Trishan Vaikunthanathan, Katie Lowe, Laura Fry, Cristiano Scottà, Nathali Grageda, Wayel Jassem and Alberto Sánchez‐Fueyo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

Sarah Thirkell

6 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Thirkell United Kingdom	3	215	99	58	39	32	8	283
Walter E. Aulitzky Germany	6	111 0.5×	38 0.4×	18 0.3×	29 0.7×	47 1.5×	8	173
Nicholas Chun United States	7	143 0.7×	20 0.2×	34 0.6×	32 0.8×	46 1.4×	17	193
Rebeca Arroyo Hornero United States	7	164 0.8×	62 0.6×	10 0.2×	13 0.3×	40 1.3×	13	244
Pete Cotter United States	4	263 1.2×	55 0.6×	75 1.3×	40 1.0×	19 0.6×	5	342
Catherine Gottschalk Germany	6	270 1.3×	77 0.8×	8 0.1×	10 0.3×	54 1.7×	7	323
Patricia Conde Spain	6	133 0.6×	25 0.3×	25 0.4×	36 0.9×	20 0.6×	9	188
A. Parissiadis France	8	97 0.5×	21 0.2×	63 1.1×	74 1.9×	10 0.3×	19	196
Karolina Gołąb United States	13	115 0.5×	92 0.9×	18 0.3×	216 5.5×	69 2.2×	33	376
Silvia Chilla Germany	6	115 0.5×	74 0.7×	10 0.2×	13 0.3×	37 1.2×	6	178
R Okuyama Japan	5	284 1.3×	85 0.9×	5 0.1×	14 0.4×	34 1.1×	6	345

Countries citing papers authored by Sarah Thirkell

Since Specialization

Citations

This map shows the geographic impact of Sarah Thirkell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Thirkell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Thirkell more than expected).

Fields of papers citing papers by Sarah Thirkell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Thirkell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Thirkell. The network helps show where Sarah Thirkell may publish in the future.

Co-authorship network of co-authors of Sarah Thirkell

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Thirkell. A scholar is included among the top collaborators of Sarah Thirkell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Thirkell. Sarah Thirkell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Sassi, Monica, Sarah Thirkell, Katy Newton, et al.. (2023). 437 Optimised achilles VELOS^TM process 2b manufacturing platform generates a significant dose boost of reactive CD8 and CD4 clonal neoantigen-reactive T cells for the treatment of solid cancer. SHILAP Revista de lepidopterología. A486–A486. 1 indexed citations

2.

Safinia, Niloufar, Nathali Grageda, Sarah Thirkell, et al.. (2018). A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. Molecular Therapy — Methods & Clinical Development. 8. 198–209. 103 indexed citations

3.

Safinia, Niloufar, Nathali Grageda, Cristiano Scottà, et al.. (2018). Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells. Frontiers in Immunology. 9. 354–354. 57 indexed citations

4.

Bushell, Andrew, David Game, Rachel Hilton, et al.. (2016). The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.. American Journal of Transplantation. 16. 798–798. 1 indexed citations

5.

Bushell, Andrew, David Game, Rachel Hilton, et al.. (2016). The UK ONE Study trial: safety and feasibility of regulatory T (Treg) cell therapy in renal transplantation. Transplantation. 100.

6.

Safinia, Niloufar, Trishan Vaikunthanathan, Sarah Thirkell, et al.. (2016). Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation. Oncotarget. 7(7). 7563–7577. 120 indexed citations

7.

Whitehouse, Gavin, Niloufar Safinia, Irene Rebollo‐Mesa, et al.. (2015). P1311 : Thril; pilot study evaluating the safety and efficacy profile of regulatory T cell therapy in liver transplant recipients. Journal of Hepatology. 62. S846–S846.

8.

Fazekasova, Henrieta, et al.. (2014). C-25. Cryobiology. 69(3). 508–508. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact